Chronic hepatitis B virus monoinfection at a university hospital in Zambia.

Simple item page
dc.contributor.affiliationDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, United States.
dc.contributor.affiliationZambian Ministry of Health, Ndeke House, Lusaka 30205, Zambia.
dc.contributor.affiliationZambia National Blood Transfusion Service, Private Bag RW1X Ridgeway, Lusaka 50110, Zambia.
dc.contributor.affiliationDepartment of Medicine, University of California at Los Angeles, Los Angeles, CA 90035, United States.
dc.contributor.affiliationTropical Gastroenterology and Nutrition Group, School of Medicine, University of Zambia, Lusaka 50110, Zambia.
dc.contributor.affiliationDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, United States.
dc.contributor.affiliationDepartment of Infectious Diseases, Bern University Hospital, University of Bern, Bern 3012, Switzerland.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia, Lusaka 34681, Zambia.
dc.contributor.affiliationBlizard Institute, Barts and The London School of Medicine, Queen Mary University of London, London E1 2AT, United Kingdom.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorVinikoor MJ
dc.contributor.authorSinkala E
dc.contributor.authorKanunga A
dc.contributor.authorMuchimba M
dc.contributor.authorNsokolo B
dc.contributor.authorChilengi R
dc.contributor.authorWandeler G
dc.contributor.authorMulenga J
dc.contributor.authorChisenga T
dc.contributor.authorBhattacharya D
dc.contributor.authorSaag MS
dc.contributor.authorFoster G
dc.contributor.authorFried MW
dc.contributor.authorKelly P
dc.date.accessioned2025-05-23T11:41:28Z
dc.date.issued2018-Sep-27
dc.description.abstractAIM: To characterize antiviral therapy eligibility among hepatitis B virus (HBV)-infected adults at a university hospital in Zambia. METHODS: Hepatitis B surface antigen-positive adults ( RESULTS: The median age was 33 years, 71.9% were men, and 30.9% were diagnosed with HBV through a clinically-driven test with the remainder identified CONCLUSION: Approximately one in ten HBV-monoinfected Zambians were eligible for antivirals. Many had indeterminate phenotype and needed clinical follow-up.
dc.identifier.doi10.4254/wjh.v10.i9.622
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10487
dc.sourceWorld journal of hepatology
dc.titleChronic hepatitis B virus monoinfection at a university hospital in Zambia.

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
article.pdf
Size:
1.08 MB
Format:
Adobe Portable Document Format
Download

Collections

Published